STOCKSCREENR
Log In

SNDX

NASDAQ

Syndax Pharmaceuticals, Inc.

$23.77-0.27(-1.12%)Mkt Cap: $2.10B

Key Stats

Market Cap

$2.10B

P/E Ratio

-7.22

EPS

$-3.29

Dividend Yield

0.00%

52-Week Range

$8.58 — $25.16

Volume

1.10M

Avg Volume

1.30M

Beta

0.46

Valuation

P/E (TTM)

-7.22

Forward P/E

—

PEG Ratio

-0.82

P/S (TTM)

12.22

P/B (TTM)

32.01

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-2.07%

ROA (TTM)

-0.54%

ROIC

—

Gross Margin

0.96%

Operating Margin

-1.58%

Net Margin

—

Debt/Equity

5.36

Current Ratio

4.40

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

-2.20%

EPS Growth (5Y)

-1.06%

Sales Growth (3Y)

-0.33%

Sales Growth (5Y)

+18.02%

EPS Est (This Year)

$-1.59

EPS Est (Next Year)

$-0.22

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$4.55

Analyst Consensus

Price Target Range

$35.00$38.00$45.00
LowMedianHigh

Consensus Target: $39.33(65.5% upside)

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

88.20M

Float

74.69M

Free Float %

84.68%

About

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

NASDAQ

IPO Date

2016-03-02

Employees

270

CEO

Michael A. Metzger

Index Membership

—

Website

https://www.syndax.com

Syndax Pharmaceuticals, Inc. (SNDX) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $2.10B, a P/E ratio of -7.22, SNDX is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare SNDX against other stocks using dozens of fundamental and technical filters.

Similar Stocks

BTX

BlackRock Technology and Private Equity Term Trust

$6.49

+1.56%

$757.45M

BHVN

Biohaven Ltd.

$9.53

-1.14%

$1.01B

VKTX

Viking Therapeutics, Inc.

$35.53

-1.33%

$4.11B

STOK

Stoke Therapeutics, Inc.

$32.87

-3.21%

$1.88B

ARDX

Ardelyx, Inc.

$5.83

-0.17%

$1.43B

KOD

Kodiak Sciences Inc.

$23.85

+2.32%

$1.26B

Frequently Asked Questions

What is Syndax Pharmaceuticals, Inc.'s P/E ratio?

Syndax Pharmaceuticals, Inc. (SNDX) has a trailing twelve-month (TTM) P/E ratio of -7.22. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Syndax Pharmaceuticals, Inc. pay a dividend?

No, Syndax Pharmaceuticals, Inc. (SNDX) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Syndax Pharmaceuticals, Inc.'s market cap?

Syndax Pharmaceuticals, Inc. (SNDX) has a market capitalization of $2.10 billion, classifying it as a mid-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.